Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma

With the growing knowledge of multiple myeloma (MM) pathobiology and the introduction of novel therapies, risk stratification continues to evolve. Myeloid-derived suppressor cells and tumor-associated macrophages, derived from peripheral blood monocytes, support malignant plasma cell proliferation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Camille V., Hassan, Hamza, Yildirim, Cenk, Ferri, Grace, Verma, Karina P., Murray Horwitz, Mara E., Fillmore, Nathanael R., Munshi, Nikhil C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979755/
https://www.ncbi.nlm.nih.gov/pubmed/36409606
http://dx.doi.org/10.1182/bloodadvances.2022008021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979755/
https://www.ncbi.nlm.nih.gov/pubmed/36409606
http://dx.doi.org/10.1182/bloodadvances.2022008021

Ejemplares similares